Induction of cancer cell-specific death via MMP2 promoterdependent Bax expression

BMB Reports

Volumn 42, Issue 4, 2009, Pages 217-222

  Seo, Eunjeong ^a   Kim, Sewoon ^a   Jho, Eek hoon ^a  

^a University of Seoul   (South Korea)

Author keywords

Cancer gene therapy; Lentivirus; MMP 2 promoter; Proapoptotic gene; Tet on inducible system

Indexed keywords

LENTIVIRUS;

CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; GELATINASE A; PROTEIN BAX; PROTEIN BID;

ARTICLE; CELL DEATH; CELL LINE; CELL STRAIN CACO 2; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HELA CELL; HUMAN; LENTIVIRINAE; NICK END LABELING; PHYSIOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BCL-2-ASSOCIATED X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CACO-2 CELLS; CELL DEATH; CELL LINE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HELA CELLS; HUMANS; IN SITU NICK-END LABELING; LENTIVIRUS; MATRIX METALLOPROTEINASE 2; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 66849131069     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2009.42.4.217     Document Type: Article

References (24)

1. Verma, I. M. and Weitzman, M. D. (2005) Gene therapy: twenty-first century medicine. Annu. Rev. Biochem. 74, 711-738.
2. Flotte, T. R. (2007) Gene therapy: the first two decades and the current state-of-the-art. J. Cell Physiol. 213, 301-305.
3. Low, P. S., Henne, W. A. and Doorneweerd, D. D. (2008) Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc. Chem. Res. 41, 120-129.
4. Haley, B. and Frenkel, E. (2008) Nanoparticles for drug delivery in cancer treatment. Urol. Oncol. 26, 57-64.
5. Gu, J. and Fang, B. (2003) Telomerase promoter-driven cancer gene therapy. Cancer Biol. Ther. 2, S64-70.
6. Yun, H. J., Cho, Y. H., Moon, Y., Park, Y. W., Yoon, H. K., Kim, Y. J., Cho, S. H., Lee, Y. I., Kang, B. S., Kim, W. J., Park, K. and Seo, W. (2008) Transcriptional targeting of gene expression in breast cancer by the promoters of protein regulator of cytokinesis 1 and ribonuclease reductase 2. Exp. Mol. Med. 40, 345-353.
7. Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W. and Bujard, H. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769.
8. Orth, P., Schnappinger, D., Hillen, W., Saenger, W. and Hinrichs, W. (2000) Structural basis of gene regulation by the tetracycline inducible Tet repressor-operator system. Nat. Struct. Biol. 7, 215-219.
9. Lin, J., Page, C., Jin, X., Sethi, A. O., Patel, R. and Nunez, G. (2001) Suppression activity of pro-apoptotic gene products in cancer cells, a potential application for cancer gene therapy. Anticancer Res. 21, 831-839.
10. Gu, J., Zhang, L., Huang, X., Lin, T., Yin, M., Xu, K., Ji, L., Roth, J. A. and Fang, B. (2002) A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo. Oncogene 21, 4757-4764.
11. Chien, A. L. and Pihie, A. H. (2003) Styrylpyrone derivative induces apoptosis through the up-regulation of Bax in the human breast cancer cell line MCF-7. J. Biochem. Mol. Biol. 36, 269-274.
12. Izawa, H., Yamamoto, H., Damdinsuren, B., Ikeda, K., Tsujie, M., Suzuki, R., Kitani, K., Seki, Y., Hayashi, T., Takemasa, I., Ikeda, M., Ohue, M., Sekimoto, M., Monden, T. and Monden, M. (2005) Effects of p21cip1/waf1 overexpression on growth, apoptosis and differentiation in human colon carcinoma cells. Int. J. Oncol. Vol. 27, 69-76.
13. Seo, Y. W., Park, S. Y., Yun, C. W. and Kim, T. H. (2006) Differential efflux of mitochondrial endonuclease G by hNoxa and tBid. J. Biochem. Mol. Biol. 39, 556-559.
14. Klein, G., Vellenga, E., Fraaije, M. W., Kamps, W. A. and de Bont, E. S. (2004) The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit. Rev. Oncol. Hematol. 50, 87-100.
15. Hanemaaijer, R., Verheijen, J. H., Maguire, T. M., Visser, H., Toet, K., McDermott, E., O'Higgins, N. and Duffy, M. J. (2000) Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors. Int. J. Cancer 86, 204-207.
16. Schmalfeldt, B., Prechtel, D., Harting, K., Spathe, K., Rutke, S., Konik, E., Fridman, R., Berger, U., Schmitt, M., Kuhn, W. and Lengyel, E. (2001) Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin. Cancer Res. 7, 2396-2404.
17. Sheen-Chen, S. M., Chen, H. S., Eng, H. L., Sheen, C. C. and Chen, W. J. (2001) Serum levels of matrix metalloproteinase 2 in patients with breast cancer. Cancer Lett. 173, 79-82.
18. Koponen, J. K., Kankkonen, H., Kannasto, J., Wirth, T., Hillen, W., Bujard, H. and Yla-Herttuala, S. (2003) Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo. Gene. Ther. 10, 459-466.
19. Miyoshi, H., Blomer, U., Takahashi, M., Gage, F. H. and Verma, I. M. (1998) Development of a self-inactivating lentivirus vector. J. Virol. 72, 8150-8157.
20. Fagotto, F., Jho, E., Zeng, L., Kurth, T., Joos, T., Kaufmann, C. and Costantini, F. (1999) Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization. J. Cell Biol. 145, 741-756.
21. Lyu, J., Costantini, F., Jho, E. H. and Joo, C. K. (2003) Ectopic expression of Axin blocks neuronal differentiation of embryonic carcinoma P19 cells. J. Biol. Chem. 278, 13487-13495.
22. Naldini, L., Blomer, U., Gage, F. H., Trono, D. and Verma, I. M. (1996) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 93, 11382-11388.
23. Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L. and Trono, D. (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15, 871-875.
24. Lewis, B. C., Chinnasamy, N., Morgan, R. A. and Varmus, H. E. (2001) Development of an avian leukosis-sarcoma virus subgroup A pseudotyped lentiviral vector. J. Virol. 75, 9339-9344.